25th Annual Trainee Research Day

On Tuesday, October 13, Fox Chase Cancer Center celebrated the 25th Trainee Research Day, an annual, all-day scientific event designed to foster a sense of community and collaboration between the Institution’s five research programs and seven clinical departments. This year’s event was held virtually through online platforms Zoom and Discord, and attracted nearly 200 research and clinical professionals from Fox Chase Cancer Center and throughout the region.

Keynote speakers
Clinical Drug Development: From Bench to Bedside
Anthony J. Olszanski, MD, RPh
Vice Chair, Associate Professor,
Department of Hematology/Oncology
Chief, Section of Solid Tumor Oncology
Co-Director, Melanoma and Skin Cancer Program
Director, Early Clinical Drug
Development Phase 1 Program
From Bench to Bedside: Lessons Learned from Studying GIST Biology
Lori Rink, PhD
Assistant Professor
Fox Chase Cancer Center
Margaret vonMehren, MD
Chief, Division of Sarcoma Medical Oncology 
Physician Director, Clinical Trials Office
Associate Director, Clinical Research
Professor, Department of Hematology/Oncology



Cancer Metabolic Ecosystems
Ubaldo Martinez Outschoorn, MD
Associate Professor of Medical Oncology
Thomas Jefferson University


Trainee presentations

Mutations in CHTF18 as a novel cause of T-B+NK+SCID
Robert Sertori, PhD
Postdoctoral Associate
Immune correlates of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
Rashida Ginwala, PhD
Postdoctoral Associate

Combining CDk9 and K-ras inhibitors for the treatment o K-ras G12C mutant cancers
Carlos Herrera-Montavez, PhD
Postdoctoral Associate
Longitudinal analysis of the effect of change in telomere length on pancreatic cancer risk
Joseph Wise, BS
Graduate Student
Temple University - Lewis Katz School of Medicine
Viral Z-RNAs induce ZBP1-mediated nuclear envelope rupture, necroptosis, and inflammation
Chaoran Yin, PhD
Postdoctoral Associate
Differentiated tumor cells promot medulloblastoma progression through exosome secretion
Yijun Yang, PhD
Postdoctoral Associate


The synaptic protein Netrin G1 ligand (NGL-1) modulates the immunosuppressive environment in pancreatic cancer
Débora B. Vendramini Costa, PhD
Postdoctoral Associate


Patients' perceived barriers to discussing sexual health with breast cancer healthcare providers
Lauren A. Zimmaro PhD
Postdoctoral Associate



This event is made possible by the support of our generous sponsors:

Connect with Fox Chase